They also displayed higher levels of IL-8 and IL-13 and lower levels of IL-1β, IL-1ra, and GM-CSF compared to CIDP patients without NF155 antibodies. The gene discussed is IL1B; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.